Biotech
WATCH: AI could 'kill billions' if used by bad actors, Bill Gates warns
"We have created an intelligent species that in many respects is already smarter than we are," Gates said, adding that the risk of AI lies in people using it with bad intentions.
From Zurich to Rehovot: Harry Langbeheim’s paintings reveal the visual world of S.Y. Agnon
Trump administration works to strengthen defenses against potential AI bioattacks - report
Israeli plant-based protein co Plantopia raises $9m
Israeli PolyPid signs $320 million deal to sell drug preventing surgical infections in US, Canada
D-PLEX100 is designed to provide local, prolonged, and controlled antibacterial activity directly at the surgical site to prevent abdominal surgical site infections.
Israeli health-tech conference opens in Jerusalem with 1,800 participants from 40 countries
MIXiii Health-Tech.IL 2026 brought together investors, doctors, researchers, startups and global health-tech leaders, with a focus on Israeli emergency medicine, tech-bio, and technologies.
Israeli life sciences investments fell 40% in 2025, report found
Investments in Israeli life sciences companies fell sharply in 2025, dropping 40% after a recovery the previous year, according to a report by the Israel Advanced Technology Industries Association.
Startup wants to grow “headless humans” to replace lab animals
Researchers describe brainless, lab-grown human bodies engineered to host full organ systems and study disease without consciousness.
Israeli mathematician uses AI to decode human immune system
How an Israeli mathematician is using AI to decode the human immune system and transform patient treatment
Israel's overlooked challenge: Environmental damage from two years of war - from the editor
As the war winds down, Israel faces a quieter crisis – environmental damage from Gaza to the Dead Sea, alongside long-neglected ecological failures now demanding urgent attention
Immunai, Bristol Myers Squibb sign AI immune-data collaboration
The New York-based AI biotech will use its AMICA-OS platform to analyze clinical immune data for BMS, aiming to inform patient stratification, biomarkers, and trial decisions.
Israeli researchers develop SafeWax coating that could cut pesticide use by 50%
The team concluded that SafeWax is “an innovative technology with the potential to become a breakthrough in the field of sustainable crop protection.”
Arkin raises $100m for early-stage biotech fund
The main investors in Arkin Bio Ventures III together with Arkin Capital are Israeli institutional investors including Phoenix Finance, Clal Insurance, and Amitim pension fund
Israel's biotech moment: How science, data, and geopolitics are converging - opinion
Why now Is the time to invest in a deeply built, undervalued market
